Skip to main content
EPSCoR/IDeA Coalition
BIOMEDICAL RESEARCH

NIH-Supported Trial Finds No Difference in Fluid Treatment Options for Pediatric Sepsis

The largest-ever NIH-supported study to compare fluid interventions finds no significant difference in preventing major kidney damage in children treated for septic shock.

An NIH-supported clinical trial — the largest ever to compare fluid interventions to prevent major kidney damage in children treated for septic shock — found no significant difference in outcomes between the treatment options evaluated.

National coordination, local impact.

EPSCoR and IDeA programs operate in 25 states and 3 territories. Each state has a dedicated program office coordinating research investments, workforce development, and federal partnerships.

NIH-Supported Trial Finds No Difference in Fluid Treatment Options for Pediatric Sepsis — EPSCoR/IDeA Coalition